FENC - CIK 0001211583
FENNEC PHARMACEUTICALS INC. (FENC) reported net income of -$9.74B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$9.74B | -2134.2% |
| FY 2024 | -$436.00M | +97.3% |
| FY 2023 | -$16.05B | -67560.5% |
| FY 2022 | -$23.71M | -36.7% |
| FY 2021 | -$17.35M | +4.2% |
| FY 2020 | -$18.11M | -41.8% |
| FY 2019 | -$12.78M | -29.2% |
| FY 2018 | -$9.89M | -40.3% |
| FY 2017 |
FENNEC PHARMACEUTICALS INC. (FENC) reported net income of -$9.74B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, FENNEC PHARMACEUTICALS INC.'s net income declined from $4.68M to -$9.74B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$7.05M |
| -152.6% |
| FY 2016 | -$2.79M | -323.2% |
| FY 2015 | -$659.00K | +69.7% |
| FY 2014 | -$2.18M | -217.9% |
| FY 2013 | $1.84M | +135.7% |
| FY 2012 | -$5.16M | -210.2% |
| FY 2011 | $4.68M | - |